EUVIMEDEUVIMED entdecken
Crossref

Endothelial damage inhibitor preserves the integrity of venous endothelial cells from patients undergoing coronary bypass surgery

Timo Z Nazari-Shafti iD, Henriette Thau iD, Ema Zacharova, Christien M Beez, Vasileios Exarchos, Sebastian Neuber iD, Heike Meyborg, Kerstin Puhl, Corey Wittig, Robert Szulcek, Konrad Neumann, Costanza Giampietro und 6 weitere

European Journal of Cardio-Thoracic Surgery · 2023

DOI: 10.1093/ejcts/ezad327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2023. Verfasst von Timo Z Nazari-Shafti und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany. Hauptthemen laut MEDLINE: Endothelial Cells, Vascular Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: German Heart Center Berlin and institutional funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES Despite the success of coronary artery bypass graft (CABG) surgery using autologous saphenous vein grafts (SVGs), nearly 50% of patients experience vein graft disease within 10 years of surgery. One contributing factor to early vein graft disease is endothelial damage during short-term storage of SVGs in inappropriate solutions. Our aim was to evaluate the effects of a novel endothelial damage inhibitor (EDI) on SVGs from patients undergoing elective CABG surgery and on venous endothelial cells (VECs) derived from these SVGs. METHODS SVGs from 11 patients participating in an ongoing clinical registry (NCT02922088) were included in this study, and incubated with both full electrolyte solution (FES) or EDI for 1 h and then examined histologically. In 8 of 11 patients, VECs were isolated from untreated grafts, incubated with both FES and EDI for 2 h under hypothermic stress conditions and then analysed for activation of an inflammatory phenotype, cell damage and cytotoxicity, as well as endothelial integrity and barrier function. RESULTS The EDI was superior to FES in protecting the endothelium in SVGs (74 ± 8% versus 56 ± 8%, P < 0.001). Besides confirming that the EDI prevents apoptosis in SVG-derived VECs, we also showed that the EDI temporarily reduces adherens junctions in VECs while protecting focal adhesions compared to FES. CONCLUSIONS The EDI protects the connectivity and function of the SVG endothelium. Our data suggest that the EDI can preserve focal adhesions in VECs during short-term storage after graft harvesting. This might explain the superiority of the EDI in maintaining most of the endothelium in venous CABG surgery conduits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial CellsVascular DiseasesHumansSaphenous VeinVascular PatencyCoronary Artery BypassEndothelium, Vascular

Stichwörter der Autor:innen

Coronary artery bypass graft surgeryEndothelial damage inhibitorEndothelial functionIschaemia/reperfusionSaphenous vein graftVein graft disease

Autor:innen und Institutionen

  • Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany.
  • Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany.
  • German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
  • Department of Life Sciences, IMC University of Applied Sciences Krems, Krems an der Donau, Austria.
  • Department of Cardiac Anesthesiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany.

ORCID-Profile: Timo Z Nazari-Shafti, Henriette Thau, Sebastian Neuber, Volkmar Falk, Maximilian Y Emmert

Förderung

  • German Heart Center Berlin and institutional funds

Zitieren

APA

Nazari-Shafti, T. Z., Thau, H., Zacharova, E., Beez, C. M., Exarchos, V., Neuber, S., Meyborg, H., Puhl, K., Wittig, C., Szulcek, R., Neumann, K., Giampietro, C., Krüger, K., Cesarovic, N., Falk, V., Caliskan, E., Rodriguez Cetina Biefer, H., & Emmert, M. Y. (2023). Endothelial damage inhibitor preserves the integrity of venous endothelial cells from patients undergoing coronary bypass surgery. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezad327

Vancouver

Nazari-Shafti TZ, Thau H, Zacharova E, Beez CM, Exarchos V, Neuber S, et al. Endothelial damage inhibitor preserves the integrity of venous endothelial cells from patients undergoing coronary bypass surgery. European Journal of Cardio-Thoracic Surgery. 2023. doi:10.1093/ejcts/ezad327

BibTeX
@article{NazariShafti2023,
  author = {Nazari-Shafti, Timo Z and Thau, Henriette and Zacharova, Ema and Beez, Christien M and Exarchos, Vasileios and Neuber, Sebastian and Meyborg, Heike and Puhl, Kerstin and Wittig, Corey and Szulcek, Robert and Neumann, Konrad and Giampietro, Costanza and Krüger, Katrin and Cesarovic, Nikola and Falk, Volkmar and Caliskan, Etem and Rodriguez Cetina Biefer, Hector and Emmert, Maximilian Y},
  title = {Endothelial damage inhibitor preserves the integrity of venous endothelial cells from patients undergoing coronary bypass surgery},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2023},
  doi = {10.1093/ejcts/ezad327}
}
Kostenlos starten →